Citations

Showing 10 of 108083 citations.

Gender-Specific Differences in Serum Immunoglobulin E Levels and Prevalence of Fungus in Sinonasal Tissue Noted in Patients with Chronic Rhinosinusitis who Underwent Endoscopic Sinus Surgery
Azar, Antoine , Rank, Matthew A. , Zarka, Matthew A., Lai, Devyani, Chang, Yu‐Hui

Mayo Clinic

American Journal of Rhinology & Allergy | November 9, 2017 | Volume: 31 | Issue: 6 | Pages: 370-375

10.2500/ajra.2017.31.4471 | PMID 29122081 Get It

Background We previously presented that women with chronic rhinosinusitis (CRS) who elected endoscopic sinus surgery (ESS) have a higher symptom burden than men. Causes of these gender-based differences warranted further study. Objectives To study gender differences in another cohort of adult patients with CRS who underwent ESS and to compare key histopathologic and serologic features Methods Patients with CRS who underwent ESS (from 2011 to 2014) with structured histopathology reports on surgical samples were studied. The 13-item structured histopathology report detailed key metrics of inflammation and the presence of fungal elements. Clinical, 22-item Sino-Nasal Outcome Test (SNOT-22) score, Lund-Mackay computed tomography (CT) score, serologic (immunoglobulin E [IgE] level, absolute eosinophil count) and histopathologic data were compared between male and female patients by using statistical software. Results We studied 130 eligible subjects (mean age, 54.7 years; 49.2% women). Compared with the men, the women had significantly higher preoperative SNOT-22 scores (women, 48.7; men 38.0 [p = 0.004]) but similar CT scores. Serum IgE levels were significantly higher among women versus men (peak, 433.3 versus 190.8 kU/L [p = 0.03]; closest to surgery, 435.0 versus 190.8 kU/L [p = 0.03]). Tissue fungal elements were significantly more prevalent in women versus men (19.0 versus 5.2%; p = 0.02). Up to this point, the analysis was agnostic of clinical details of the subjects. Further analysis was conducted regarding clinical features. Allergic fungal sinusitis (AFS) was found significantly more commonly in the female versus male patients (21.9 versus 9.1%; p = 0.04). Women versus men had a higher prevalence of migraine (19.4 versus 4.6%; p = 0.01) or any primary headache disorders (23.0 versus 6.2%; p = 0.007). Conclusion Women who underwent ESS for CRS had higher SNOT-22 symptom burden. Worsened symptomatology may be secondary to a higher prevalence of primary headache disorders in women. However, surgeons should also be aware that female patients with CRS who seek ESS may have a higher prevalence of severe disease endotypes (more tissue fungal elements, elevated serum IgE levels) and phenotypes.
Posology for Regenerative Therapy
Behfar, Atta , Behfar, Atta , Terzic, André

Mayo Clinic

Circulation Research | November 9, 2017 | Volume: 121 | Issue: 11 | Pages: 1213-1215

10.1161/circresaha.117.312074 | PMID 29122941 Get It

Alcohol Drinking and Blood Alcohol Concentration Revisited
Nicholson, Emily R., Fischer, Stephen M. , Zimmer, Robin, Froehlich, Janice C., Froehlich, Janice C , Dilley, Julian E.

Mayo Clinic

Alcoholism: Clinical and Experimental Research | November 9, 2017 | Volume: 42 | Issue: 2 | Pages: 260-269

10.1111/acer.13549 | PMID 29121399 Get It

BackgroundIt is widely assumed that the amount of alcohol in the blood reflects the amount of alcohol consumed. However, several factors in addition to amount of alcohol consumed can influence blood alcohol concentration (BAC). This study examines the effect of alcohol dose, concentration, and volume onBACin rats with a high‐alcohol‐drinking (HAD) phenotype.MethodsStudy 1 examined the relationship between the amount of alcohol consumed andBAC. Alcohol‐naïve, male,HADrats (N = 7) were given access to alcohol for 2 h/d for 9 consecutive days with food and water ad libitum. Alcohol intake andBACwere measured at 30, 60, and 90 minutes after onset of access. Study 2 examined the effects of altering alcohol dose, concentration, and volume onBAC(as measured by area under the curve). Alcohol‐naïve, male,HADrats (N = 39) were infused, via an intragastric cannulus, with 1.16, 2.44, or 3.38 g alcohol/kg body weight (BW), produced by varying alcohol volume while holding concentration constant or by holding volume constant while varying concentration. Other rats were infused with 10, 15, or 20% v/v alcohol solutions while holding dose constant.ResultsBACwas more strongly correlated with the ratio of alcohol intake (g/kgBW) to total fluid intake (mls) (R = 0.85 to 0.97,p < 0.05 top < 0.001) than it was with the amount of alcohol consumed (g/kgBW) (R = 0.70 to 0.81,p < 0.05). No effect of alcohol dose was seen during the first hour following the onset of an alcohol infusion regardless of whether dose was achieved by altering alcohol volume or concentration. After 1 hour, higher alcohol doses were predictive of greaterBACs.ConclusionsThe fact that a 3‐fold difference in alcohol dose did not result in significant differences inBACs during the first 30 minutes after ingestion of alcohol has potentially important implications for interpretation of studies that measure alcohol‐sensitive end points during this time.
Pulmonary Neuroendocrine Cell Hyperplasia Associated with Surfactant Protein C Gene Mutation
Jiramethee, Norlalak , Erasmus, D , Nogee, Lawrence M. , Khoór, András , Erasmus, David, Nogee, Lawrence

Mayo Clinic

Case Reports in Pulmonology | November 9, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-6

10.1155/2017/9541419 | PMID 29250453 Get It

Familial interstitial lung disease (ILD) is defined as presence of ILD in 2 or more family members. Surfactant protein C (SFTPC) gene mutations are rare, but well-known cause of familial ILD. We reported a 20-year-old male, who was referred for lung transplantation. He was symptomatic at age 3 and underwent surgical lung biopsy at age 6, which revealed a nonspecific interstitial pneumonia (NSIP) pattern. Genetic workup revealed a novel SFTPC mutation in the first intron with a C to A transversion. At age 21, he underwent bilateral lung transplantation. Explanted lung histology suggested NSIP. In addition there was pulmonary neuroendocrine cell (PNEC) hyperplasia and carcinoid tumorlets. His mother had undergone lung transplantation several years earlier, and her explanted lung showed similar pathology. SFTPC mutations are inherited in an autosomal dominant pattern. Various types of ILD have been associated with SFTPC mutation including NSIP, usual interstitial pneumonia (UIP), and desquamative interstitial pneumonia (DIP). PNEC hyperplasia has been described to occur in association with lung inflammation but has not been previously described with familial ILD associated with SFTPC mutation.
Becoming Friends of Time: Disability, Timefullness, and Gentle Discipleship. John Swinton. 2016
Piderman, Katherine M.

Mayo Clinic

Journal of Health Care Chaplaincy | November 9, 2017 | Volume: 24 | Issue: 1 | Pages: 40-42

10.1080/08854726.2017.1383579 Get It

Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide
Supekar, Nitin T. , Lakshminarayanan, Vani , Capicciotti, Chantelle J. , Sirohiwal, Anju, Madsen, Cathy S., Wolfert, Margreet A. , Cohen, Peter A. , Gendler, Sandra , Boons, Geert‐Jan , Gendler, Sandra J

Mayo Clinic

ChemBioChem | November 9, 2017 | Volume: 19 | Issue: 2 | Pages: 121-125

10.1002/cbic.201700424 | PMID 29120508 Get It

AbstractA fully synthetic MUC1‐based cancer vaccine was designed and chemically synthesized containing an endogenous helper T‐epitope (MHC class II epitope). The vaccine elicited robust IgG titers that could neutralize cancer cells by antibody‐dependent cell‐mediated cytotoxicity (ADCC). It also activated cytotoxic T‐lymphocytes. Collectively, the immunological data demonstrate engagement of helper T‐cells in immune activation. A synthetic methodology was developed for a penta‐glycosylated MUC1 glycopeptide, and antisera of mice immunized by the new vaccine recognized such a structure. Previously reported fully synthetic MUC1‐based cancer vaccines that elicited potent immune responses employed exogenous helper T‐epitopes derived from microbes. It is the expectation that the use of the newly identified endogenous helper T‐epitope will be more attractive, because it will activate cognate CD4+ T‐cells that will provide critical tumor‐specific help intratumorally during the effector stage of tumor rejection and will aid in the generation of sustained immunological memory.
Orthopedic complications of linear morphea: Implications for early interdisciplinary care
Schoch, Jennifer J. , Schoch, Bradley S. , Werthel, Jean David, McIntosh, Amy L. , Davis, Dawn Marie R. , Davis, Dawn M R , Schoch, Bradley S , Werthel, Jean-David

Mayo Clinic

Pediatric Dermatology | November 9, 2017 | Volume: 35 | Issue: 1 | Pages: 43-46

10.1111/pde.13336 | PMID 29119592 Get It

AbstractLinear morphea of the limb primarily affects children, and extracutaneous manifestations are common. Orthopedic surgeons are often essential in the care of patients with linear morphea, yet there are few reports outlining specific orthopedic complications in this population. We sought to improve the understanding of orthopedic complications in linear morphea of the limb. Between 1999 and 2014, 51 children were evaluated for linear morphea of an extremity. Twenty‐six (51%) had documented orthopedic manifestations. Outcome measures included limb length discrepancy, angular malalignment, limb atrophy, and orthopedic surgical intervention. Joint contractures were most common, affecting 88% of patients, followed by limb atrophy, angular deformity, and limb length discrepancy; 14% required surgical intervention. Despite the use of systemic immunosuppressive therapy in many patients, approximately half of patients with linear morphea of an extremity have orthopedic disease. Early orthopedist involvement is crucial to improve limb alignment and preserve function.
Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid‐naïve patients
Malderen, Kathleen Van , Halawi, Houssam , Camilleri, Michael , Camilleri, M

Mayo Clinic

Neurogastroenterology & Motility | November 9, 2017 | Volume: 30 | Issue: 5 | Pages: No page available

10.1111/nmo.13250 | PMID 29119706 Get It

AbstractBackgroundOpioid‐induced constipation (OIC) is a major side effect of opioid use. Centrally acting antagonists result in opioid withdrawal or worsening of pain and lead to use of peripherally acting mu‐opioid receptor antagonists (PAMORAs). The required doses of the PAMORAs, methylnaltrexone and naloxegol, in the treatment of OIC are well established in chronic opioid users. OIC may occur after short duration of opioid treatment; the required doses of naloxone, naltrexone, and PAMORAs in opioid‐naïve subjects (with no opioid use for at least 3 months) are unclear. The aim of this review was to evaluate the PAMORA dose required for opioid‐naïve subjects to achieve similar beneficial effects on symptoms or valid surrogates to those observed in chronic opioid users.MethodsA PubMed search of μ‐opioid antagonists to counter μ‐opioid effects included terms: naloxone, naltrexone, methylnaltrexone, alvimopan, and naloxegol, as well as OIC and colonic transit.Key ResultsThe approved dose of methylnaltrexone in chronic opioid users, 0.3 mg/kg subcutaneous (SQ), did not affect motility in opioid‐naïve subjects. Trials investigating the required dose of alvimopan showed 0.5‐1 mg dose was efficacious in treating OIC; a 10‐fold higher dose (12 mg) of alvimopan is needed to block effects of codeine on small bowel and colonic transit in opioid‐naïve subjects compared to chronic opioid users. Opioid‐naïve users need 125 mg of naloxegol to reverse the effects of opioids on transit; this is in contrast to the 12.5 to 25 mg needed to treat OIC in chronic opioid users.Conclusions & InferencesOpioid‐naïve subjects require a higher dose of PAMORA than chronic opioid users to achieve μ‐opioid antagonist effect.
Librarians Without Borders: Building In-Country Research and Information Provision Capability
Funk, Carla J., Homan, J. Michael, Rhine, Lenny

Mayo Clinic

Against the Grain | November 9, 2017 | Volume: 26 | Issue: 2 | Pages: No page available

10.7771/2380-176x.6693 Get It

An integrative approach to assess X‐chromosome inactivation using allele‐specific expression with applications to epithelial ovarian cancer
Larson, Nicholas B. , Fogarty, Zachary C. , Kalli, Kimberly R., Lawrenson, Kate , Gayther, Simon A. , Goode, Ellen L. , Winham, Stacey J. , Winham, Stacey J , Lawrenson, Kate , Fogarty, Zachary C , Larson, Nicholas B , Larson, Melissa C. , Fridley, Brooke L.

Mayo Clinic

Genetic Epidemiology | November 9, 2017 | Volume: 41 | Issue: 8 | Pages: 898-914

10.1002/gepi.22091 | PMID 29119601 Get It

ABSTRACTX‐chromosome inactivation (XCI) epigenetically silences transcription of an X chromosome in females; patterns of XCI are thought to be aberrant in women's cancers, but are understudied due to statistical challenges. We develop a two‐stage statistical framework to assess skewed XCI and evaluate gene‐level patterns of XCI for an individual sample by integration of RNA sequence, copy number alteration, and genotype data. Our method relies on allele‐specific expression (ASE) to directly measure XCI and does not rely on male samples or paired normal tissue for comparison. We model ASE using a two‐component mixture of beta distributions, allowing estimation for a given sample of the degree of skewness (based on a composite likelihood ratio test) and the posterior probability that a given gene escapes XCI (using a Bayesian beta‐binomial mixture model). To illustrate the utility of our approach, we applied these methods to data from tumors of ovarian cancer patients. Among 99 patients, 45 tumors were informative for analysis and showed evidence of XCI skewed toward a particular parental chromosome. For 397 X‐linked genes, we observed tumor XCI patterns largely consistent with previously identified consensus states based on multiple normal tissue types. However, 37 genes differed in XCI state between ovarian tumors and the consensus state; 17 genes aberrantly escaped XCI in ovarian tumors (including many oncogenes), whereas 20 genes were unexpectedly inactivated in ovarian tumors (including many tumor suppressor genes). These results provide evidence of the importance of XCI in ovarian cancer and demonstrate the utility of our two‐stage analysis.